High-grade squamous intraepithelial lesions

Cancer Journal

Volumn 9, Issue 5, 2003, Pages 382-389

  Lambrou, Nicholas C ^a,b   Twiggs, Leo B ^a,b  

^a University of Miami ^*

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CARCINOMA IN SITU; CELL DAMAGE; DISEASE SEVERITY; HEALTH CARE ORGANIZATION; HISTOPATHOLOGY; HUMAN; NOMENCLATURE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA; CELL TRANSFORMATION; COLPOSCOPY; FEMALE; PATHOLOGY; REVIEW; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VAGINA SMEAR;

CELL TRANSFORMATION, NEOPLASTIC; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; FEMALE; HUMANS; NEOPLASMS, SQUAMOUS CELL; VAGINAL SMEARS;

EID: 1542754884     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200309000-00008     Document Type: Article

References (47)

1. Wright TC. Pathogenesis and diagnosis of preinvasive lesions of the lower genital tract. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology, 3rd ed. Philadelphia: Lippincou Williams & Wilkins, 2000:735.
2. Larsen NS. Invasive cervical cancer arising in young white females. J Natl Cancer Inst 1994;86:6.
3. Kurman RJ, Hensen DE, Herbst AL et al. Interim guidelines for management of abnormal cervical cytology: the 1992 National Cancer Institute Workshop. JAMA 1994;271:1866.
4. Jones HW. The Bethesda System. Cancer 1995;76[suppl]:1914.
5. Cocker J, Fox H, Langley FA. Consistency in the histological diagnosis of epithelial abnormalities of the cervix uteri. J Clin Pathol 1968;21:67.
6. Richart RM. Cervical intraepithelial neoplasia: a review. Pathol Annu 1973;8:301.
7. Jones BA, Davey DD. Quality management in gynecologic cytology using interlaboratory comparison. Arch Pathol Lab Med 2000;124:672-681.
8. Kinney WK, Manos MM, Hurley LB et al. Where's the high-grade cervical neoplasia? Obstet Gynecol 1998;91:973-976.
9. Massad LS, Collins YC, Meyer PM. Biopsy correlates of abnormal cervical cytology classified using the Bethesda system. Gynecol Oncol 2001;82:516-522.
10. Ling FW, Cox JT, Lipscomb GH et al., eds. Advances in the Screening, Diagnosis, and Treatment of Cervical Disease, APGO Educational Series on Women's Health Issues. APGO, Washington, DC, 2002.
11. Melnikow J, Nuovo J, Willan AR et al. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998;92:727-735.
12. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12:186.
13. Richart RM, Barron BA. A follow-up study of patients with cervical dysplasia. Am J Obstet Gynecol 1969;105:386.
14. Holowaty P, Miller AB, Rohan T et al. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999;91:252-258.
15. Montz FJ. Management of high-grade cervical intraepithelial neoplasia and low-grade squamous intraepithelial lesion and potential complications. Clin Obstet Gynecol 2000;43:294-409.
16. Paterson-Brown S, Chappatte OA, Clark SK et al. The significance of cone biopsy resection margins. Gynecol Oncol 1992;46:182-185.
17. Zaitoun AM, McKee G, Coppen SM et al. Completeness of excision and follow up cytology in patients treated with loop excision biopsy. J Clin Pathol 2000;53:191-196.
18. Chang D-Y, Cheng W-F, Torng P-L et al. Prediction of residual neoplasia based on histopathology and margin status of conization specimens. Gynecol Oncol 1996;63:53-56.
19. Phelps J, Ward J, Szigeti J et al. Cervical cone margins as a predictor for residual dysplasia in post-cone hysterectomy specimens. Obstet Gynecol 1994;84:128-130.
20. Livasy CA, Maygarden SJ, Rajaratnam CT et al. Predictors of recurrent dysplasia after a cervical loop electrocautery excision procedure for CIN-3: as study of margin, endocervical gland, and quadrant involvement. Mod Pathol 1998;12:233.
21. Wright TC, Cox JT, Massad LS et al. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-2129.
22. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations. JAMA 2001;285:1500-1505.
23. Brown FM, Faquin WC, Sun D et al. LSIL biopsies after HSIL smears. Am J Clin Pathol 1999;112:765-768.
24. Chappatte OA, Byrne DL, Raju KS et al. Histological differences between colposcopic-directed biopsy and loop excision (LETZ). Gynecol Oncol 1991;43:46-50.
25. Milne DS, Wadehra V, Mennim D et al. A prospective follow up study of women with colposcopically unconfirmed positive cervical smears. Br J Obstet Gynaecol 1999;106:38-41.
26. Joste NE, Rushing L, Granados R et al. Bethesda classification of cervicovaginal smears: reproducibility and viral correlates. Hum Pathol 1996;27:581-585.
27. Bigrigg A, Haffenden DK, Sheehan AL et al. Efficacy and safety of large-loop excision of the transformation zone. Lancet 1994;343:32-34.
28. Denny LA, Soeters R, Dehaeck K et al. Does colposcopically directed punch biopsy reduce the incidence of negative LLETZ? Br J Obstet Gynaecol 1995;102:545-548.
29. Holschneider CH, Felix JC, Satmary W et al. A single-visit cervical carcinoma prevention program offered at an inner city church: a pilot project. Cancer 1999;86:2659-2667.
30. Santos C, Galdos R, Alvarez J et al. One-session management of cervical intraepithelial neoplasia. Gynecol Oncol 1996;61:11-15.
31. Bigrigg MA, Codling BW, Pearson P et al. Colposcopic diagnosis and treatment of cervical dysplasia at a single clinic visit. Lancet 1990;336:229-231.
32. Luesley DM, Cullimore J, Redman CWE et al. LOOP diathermy excision of the cervical transformation zone in patients with abnormal cervical smears. BMJ 1990;300:1690-1693.
33. Ferris DG, Hainer BL, Pfenninger JL et al. "See and treat" electrosurgical loop excision of the cervical transformation zone. J Fam Practice 1996;42:253.
34. Hacker NF, Berek JS, Lagasse LD et al. Carcinoma of the cervix associated with pregnancy. Obstet Gynecol 1982;59:735-746.
35. Shivvers SA, Miller DS. Preinvasive and invasive breast and cervical cancer prior to or during pregnancy. Clin Perinatol 1997;24:369-389.
36. Bristow RE, Montz FJ. Cervical cancer in pregnancy. In: Trimble EL, Trimble CL, eds. Cancer Obstetrics and Gynecology. Philadelphia: Lippincott, Williams & Wilkins 1999:157-175.
37. Benedet JL, Selke PA, Nickerson KG. Colposcopic evaluation of abnormal Papanicolaou smears in pregnancy. Am J Obstet Gynecol 1987;157:932-937.
38. Creasman WT, Rutledge FN, Fletcher GH. Carcinoma of the cervix associated with pregnancy. Am J Obstet Gynecol 1970;36:495-501.
39. DePetrillo AD, Townsend DE, Morrow CP et al. Colposcopic evaluation of the abnormal Papanicolaou test in pregnancy. Am J Obstet Gynecol 1975;121:441-445.
40. Fowler WC, Walton LA, Edelman DA. Cervical intraepithelial neoplasia during pregnancy. South Med J 1980;73:1180-1185.
41. Yoonessi M, Wiechkowska W, Mariniello D et al. Cervical intraepithelial neoplasia in pregnancy. Int J Gynaecol Obstet 1982;20:111-118.
42. Wright TC, Ellerbrock TV, Chiasson MA et al. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears: New York Cervical Disease Study. Obstet Gynecol 1994;84:591.
43. Kuhn L, Sun XW, Wright TC. Human immunodeficiency virus infection and female lower genital tract malignancy. Curr Opin Obstet Gynecol 1999;11:35.
44. Maiman M. Management of cervical neoplasia in human immunodeficiency virus-infected women. J Natl Cancer Inst 1998;23:43.
45. Robinson WR, Freeman D. Improved outcome of cervical neoplasia in HIV-infected women in the era of highly-active antiretroviral therapy. AIDS Patient Care STDS 2002;16:61-65.
46. Lillo FB, Ferrari D, Veglia F et al. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 2001;184:547-551.
47. Dorrucci M, Sulilgoi B, Serraino D et al. Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2001;26:377-380.